510(k) K940233
K940233 is an FDA 510(k) premarket notification submitted by Pantex for the device "NEOSCREEN ELISA HYDROXYPROGESTERONE". The FDA issued a decision of Substantially Equivalent on Dec 28, 1994. The device falls under product code JLX (Radioimmunoassay, 17-Hydroxyprogesterone), a Class I device regulated under 21 CFR 862.1395.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Dec 28, 1994
- Date Received
- Jan 18, 1994
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Radioimmunoassay, 17-Hydroxyprogesterone
- Device Class
- Class I
- Regulation Number
- 862.1395
- Review Panel
- CH
- Submission Type
- 510(k) Exempt
Need the full FDA record for Pantex? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.